Compositions and methods for production of myrcene
Provided herein are compositions and methods for producing myrcene by culturing genetically modified microbial host cells that express a myrcene synthase and optionally a geranyl pyroplosphate synthase. Also provided herein are isolated nucleic acid molecules that encode myrcene synthase variants derived from the Ocimum species myrcene synthase, which comprise one or more amino acid substitutions that improve in vivo performance of myrcene synthase in genetically modified microbial host cells. Also provided herein are isolated myrcene synthase variants that exhibit an improved activity for converting geranyl diphosphate into myrcene.
1. An isolated mutant myrcene synthase having at least 90% amino acid sequence identity to SEQ ID NO: 2 and exhibiting an improved activity for converting geranyl diphosphate into myrcene compared to the activity of a myrcene synthase of SEQ ID NO: 2 under identical reaction conditions, wherein said mutant myrcene synthase comprises a variant amino acid residue located at one or more of positions 27, 28, 213, 342, 347, 381, 390, 401, 428, 439, 466, 482, 484, 505, 514, 517, 524, 527, 528, 543, 544, and 552, wherein the positions are numbered with reference to SEQ ID NO: 2.
2. The isolated mutant myrcene synthase of claim 1 , wherein said mutant myrcene synthase comprises at least one variant amino acid residue selected from the group consisting of H27I, H27C, S28H, K213C, K213H, K213R, K213V, C342L, Y347R, F381L, G390D, N401I, N401V, V428L, Y439L, A466C, A466S, R482C, R482D, R482H, R482I, R482L, R482N, R482V, H484Y, C505I, C505L, C505V, G514L, G514V, S517G, F524L, F524V, V527C, V527F, V527H, V527L, V527N, V527S, V527Y, E528D, M543I, A544S, and Q552R, wherein the positions are numbered with reference to SEQ ID NO: 2.
3. The isolated mutant myrcene synthase of claim 1 , wherein said mutant myrcene synthase comprises at least one set of variant amino acid residues compared to SEQ ID NO: 2, and wherein the at least one set of variant amino acid residues is selected from the group of sets of variant amino acid residues consisting of:
(a) F381L, I404V, E528D, and M543I;
(b) I404V and E528D;
(c) F381L, D389G, I404V, Y439L, and E528D;
(d) F381L, E528D, and M543I;
(e) F381L, I404V, and E528D;
(f) F381L, I404V, E528D, and A544S; and
(g) F381L, I404V, E528D, and Q552R,
wherein the positions are numbered with reference to SEQ ID NO: 2.
4. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, and E528D compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
5. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, E528D, and M543I compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
6. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues I404V and E528D compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
7. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, D389G, I404V, Y439L, and E528D compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
8. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, E528D, and M543I compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
9. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, E528D, and A544S compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
10. The isolated mutant myrcene synthase of claim 1 , wherein the myrcene synthase comprises variant amino acid residues F381L, I404V, E528D, and Q552R compared to SEQ ID NO: 2, wherein the positions are numbered with reference to SEQ ID NO: 2.
11. The isolated mutant myrcene synthase of claim 1 , wherein the isolated mutant myrcene synthase has at least 95% amino acid sequence identity to SEQ ID NO: 2.
12. The isolated mutant myrcene synthase of claim 1 , wherein the isolated mutant myrcene synthase has at least 96% amino acid sequence identity to SEQ ID NO: 2.
13. The isolated mutant myrcene synthase of claim 1 , wherein the isolated mutant myrcene synthase has at least 97% amino acid sequence identity to SEQ ID NO: 2.
14. The isolated mutant myrcene synthase of claim 1 , wherein the isolated mutant myrcene synthase has at least 98% amino acid sequence identity to SEQ ID NO: 2.
15. The isolated mutant myrcene synthase of claim 1 , wherein the isolated mutant myrcene synthase has at least 99% amino acid sequence identity to SEQ ID NO: 2.